Welcome to LookChem.com Sign In|Join Free

CAS

  • or

19797-09-2

2H-Azepin-2-one, hexahydro-1-(1-methylethyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

19797-09-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 19797-09-2 Structure

  • Basic information

    1. Product Name: 2H-Azepin-2-one, hexahydro-1-(1-methylethyl)-
    2. Synonyms:
    3. CAS NO:19797-09-2
    4. Molecular Formula: C9H17NO
    5. Molecular Weight: 155.24
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 19797-09-2.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 2H-Azepin-2-one, hexahydro-1-(1-methylethyl)-(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2H-Azepin-2-one, hexahydro-1-(1-methylethyl)-(19797-09-2)
    11. EPA Substance Registry System: 2H-Azepin-2-one, hexahydro-1-(1-methylethyl)-(19797-09-2)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 19797-09-2(Hazardous Substances Data)

19797-09-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 19797-09-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,7,9 and 7 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 19797-09:
(7*1)+(6*9)+(5*7)+(4*9)+(3*7)+(2*0)+(1*9)=162
162 % 10 = 2
So 19797-09-2 is a valid CAS Registry Number.

19797-09-2Downstream Products

19797-09-2Relevant articles and documents

Development of prohibitin ligands against osteoporosis

Tabti, Redouane,Lamoureux, Fran?ois,Charrier, Céline,Ory, Benjamin,Heymann, Dominique,Bentouhami, Embarek,Désaubry, Laurent

, (2021)

Current therapeutic approaches to osteoporosis display some potential adverse effects and a limited efficacy on non-vertebral fracture reduction. Some sulfonylamidines targeting the scaffold proteins prohibitins-1 and 2 (PHB1/2) have been showed to inhibit the formation of osteoclasts in charge of bone resorption. Herein, we report the development of a second generation of anti-osteoclastic PHB ligands. The most potent compound, IN45, showed 88% inhibition at the low concentration of 5 μM, indicates that it might serve as a basis for the development of new antiosteoporotic drugs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 19797-09-2